TWiV 888: Molnupiravir with Richard Plemper

April 14, 2022

Richard joins TWiV to discuss the SARS-CoV-2 antiviral drug Molnupiravir , including how it was discovered, its mechanism of action, whether it is a mutagen for cells, and the future of drugs for treatment of COVID-19.

Hosts: Vincent Racaniello, Alan Dove, and Brianne Barker

Guest: Richard Plemper

Click arrow to play
Download TWiV 888 (65 MB .mp3, 108 min)
Subscribe (free): Apple PodcastsGoogle PodcastsRSSemail

Become a patron of TWiV!

Weekly Picks 1:19:25

BrianneBioRender Poster Builder
AlanHexbug cat toys
Vincent US Mint 2019 American Innovation Coin – PA – Polio Vaccine

Listener Picks

SueAmerican Visionary Art Museum
FrazerVaccine trial for killer elephant virus

Intro music is by Ronald Jenkees

Send your virology questions and comments to

Leave a Reply

Your email address will not be published. Required fields are marked *

3 comments on “TWiV 888: Molnupiravir with Richard Plemper

  1. H. Bradford Hawley, MD Apr 15, 2022

    Be assured that our current healthcare system is cleverly designed to thwart any attempts at early effective oral coronavirus antiviral agents. Only physicians and not pharmacists can prescribe these agents. Physicians will require confirmatory PCR tests and possibly office visits before prescribing antivirals and this delay will result in a delay beyond the 36 hours suggested by Dr Plemper for effective Rx. We know how this happens because it has happened for years in the treatment of influenza with oral agents.

  2. Hello Vincent
    I just got an idea I wanted to share with you. Please consider Dr Ginger Campbell to be a host on TWIN. She does the Brain Science Podcast and I learned about TWIV from her.